Literature DB >> 18196470

Recurrent atrioventricular nodal re-entrant tachycardia treated with percutaneous ablation in a 75-year old patient undergoing intermittent hemodialysis.

Aniela M Ratajewska1, Wojciech W Banachowicz, Alicja E Grzegorzewska.   

Abstract

A 75-year old man with long-term arterial hypertension was diagnosed in 1998 with stage 3 chronic kidney disease due to hypertensive nephropathy. Since May 2004 the patient has been treated with intermittent hemodialysis. Since 1998 he has been hospitalized several times because of palpitations in the course of paroxysmal tachycardia with narrow QRS complexes. Initially, class I antiarrhythmic agents were administered; afterwards therapy with beta-adrenolytics was introduced. Because of the ineffectiveness of monotherapy, beta-adrenolytic therapy was combined with amiodarone; however, side effects of this treatment in a form of drug-induced bradycardia appeared. During an invasive electrophysiological investigation, a typical recurrent atrioventricular nodal reentrant tachycardia (AVNRT) was repeatedly released. Subsequently performed percutaneous ablation resulted in effective modification of the slow pathway. During 25 months of follow up after the procedure, recurrence of AVNRT was not observed. Effectiveness of ablation and low risk of adverse effects in non-dialyzed patients encourage us to recommend this method of AVNRT treatment also in patients undergoing intermittent hemodialysis.

Entities:  

Mesh:

Year:  2008        PMID: 18196470     DOI: 10.1007/s11255-007-9302-y

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  11 in total

1.  [Typical AV nodal reentry tachycardia in 4 anterograde AV nodal pathways. Successful high frequency ablation of slow AV nodal pathways].

Authors:  L Obergassel; P Weismüller; K Kattenbeck; P Pfitzner; M Achtelik; H J Trappe
Journal:  Med Klin (Munich)       Date:  1999-07-15

2.  Atrioventricular nodal reentry tachycardia: slow pathway ablation using the transseptal approach.

Authors:  C Sorbera; M Cohen; P Woolf; S R Kalapatapu
Journal:  Pacing Clin Electrophysiol       Date:  2000-09       Impact factor: 1.976

3.  Pharmacokinetics and efficacy of carvedilol in chronic hemodialysis patients with hypertension.

Authors:  S Miki; H Masumura; Y Kaifu; S Yuasa
Journal:  J Cardiovasc Pharmacol       Date:  1991       Impact factor: 3.105

4.  Anatomic and functional characteristics of a slow posterior AV nodal pathway: role in dual-pathway physiology and reentry.

Authors:  D Medkour; A E Becker; K Khalife; J Billette
Journal:  Circulation       Date:  1998-07-14       Impact factor: 29.690

Review 5.  "AV nodal" reentry: Part II: AV nodal, AV junctional, or atrionodal reentry?

Authors:  M A McGuire; M J Janse; D L Ross
Journal:  J Cardiovasc Electrophysiol       Date:  1993-10

6.  Histological examination of the topography of the atrioventricular nodal artery within the triangle of Koch.

Authors:  D Kozlowski; E Kozluk; M Adamowicz; M Grzybiak; F Walczak; E Walczak
Journal:  Pacing Clin Electrophysiol       Date:  1998-01       Impact factor: 1.976

7.  Posterior extensions of the human compact atrioventricular node: a neglected anatomic feature of potential clinical significance.

Authors:  S Inoue; A E Becker
Journal:  Circulation       Date:  1998-01-20       Impact factor: 29.690

8.  Antihypertensive treatment with a vasodilating beta-blocker, carvedilol, in chronic hemodialysis patients.

Authors:  A Deetjen; A Heidland; A Pangerl; W Meyer-Sabellek; R M Schaefer
Journal:  Clin Nephrol       Date:  1995-01       Impact factor: 0.975

9.  High resolution mapping of Koch's triangle using sixty electrodes in humans with atrioventricular junctional (AV nodal) reentrant tachycardia.

Authors:  M A McGuire; J P Bourke; M C Robotin; D C Johnson; W Meldrum-Hanna; G R Nunn; J B Uther; D L Ross
Journal:  Circulation       Date:  1993-11       Impact factor: 29.690

10.  Pharmacokinetics and efficacy of carvedilol in hypertensive patients with chronic renal failure and hemodialysis patients.

Authors:  H Masumura; S Miki; Y Kaifu; W Kitajima; Y Abe
Journal:  J Cardiovasc Pharmacol       Date:  1992       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.